Egfr Mutation Positive Non Small Cell Lung Cancer clinical trials

Explore recruiting egfr mutation positive non small cell lung cancer clinical trials.

Recruiting egfr mutation positive non small cell lung cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Egfr Mutation Positive Non Small Cell Lung Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III, randomized, double-blind, placebo-controlled, multicenter, international study of Osimertinib as maintenance therapy in patients with locally advanced, unresectable EGFR mutation-positive Non-Small Cell Lung Cancer (Stage III) whose disease has not progressed following definitive platinum-based chemoradiation therapy (LAURA).

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Egfr Mutation Positive Non Small Cell Lung Cancer trials by city

Egfr Mutation Positive Non Small Cell Lung Cancer in Toronto Egfr Mutation Positive Non Small Cell Lung Cancer in Vancouver Egfr Mutation Positive Non Small Cell Lung Cancer in Montreal Egfr Mutation Positive Non Small Cell Lung Cancer in Calgary Egfr Mutation Positive Non Small Cell Lung Cancer in Edmonton Egfr Mutation Positive Non Small Cell Lung Cancer in Ottawa Egfr Mutation Positive Non Small Cell Lung Cancer in Winnipeg Egfr Mutation Positive Non Small Cell Lung Cancer in Quebec City Egfr Mutation Positive Non Small Cell Lung Cancer in Hamilton Egfr Mutation Positive Non Small Cell Lung Cancer in Kitchener Egfr Mutation Positive Non Small Cell Lung Cancer in London Egfr Mutation Positive Non Small Cell Lung Cancer in Halifax Egfr Mutation Positive Non Small Cell Lung Cancer in New York Egfr Mutation Positive Non Small Cell Lung Cancer in Los Angeles Egfr Mutation Positive Non Small Cell Lung Cancer in Chicago Egfr Mutation Positive Non Small Cell Lung Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease